{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:59:28Z","timestamp":1781333968534,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Hydroxyethyl starch (HES) has been widely used for volume expansion, but its safety in adult patients has been questioned recently. The aim of this meta-analysis is to see whether or not HES has any adverse effect in pediatric patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Randomized controlled trials (RCTs) involving pediatric patients who received 6% low-molecular-weight HES, published before January 2014, were searched for in Pubmed, Embase database and Cochrane Library. Two reviewers independently extracted the valid data, including the mortality, renal function, coagulation, blood loss, hemodynamic changes, and length of hospital and ICU stay. All data were analyzed by <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>-test, and the results of statistical analysis were displayed in forest plots. Possible publication bias was tested by funnel plots. Bayesian analysis was performed using WinBUGS with fixed and random effects models.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 13 RCTs involving 1,156 pediatric patients were finally included in this meta-analysis. Compared with other fluids, HES did not significantly decrease the mortality (RR\u2009=\u2009-0.01; 95%CI: 0.05 to 0.03; <jats:italic>P<\/jats:italic>\u2009=\u20090.54; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20096%), creatinine level (<jats:italic>I<\/jats:italic><jats:sup><jats:italic>2<\/jats:italic><\/jats:sup>-test: MD\u2009=\u20091.81; 95%CI: -0.35 to 3.98; <jats:italic>P<\/jats:italic>\u2009=\u20090.10;<jats:italic>I<\/jats:italic><jats:sup><jats:italic>2<\/jats:italic><\/jats:sup>\u2009=\u20090%; Bayesian analysis: Fixed effect model MD\u2009=\u20091.77; 95%CI: -0.07 to 3.6; Random effects model MD\u2009=\u20091.78; 95%CI: -1.86 to 5.33), activated partial thromboplastin time (MD\u2009=\u20090.01; 95%CI: -1.05 to 1.07; <jats:italic>P<\/jats:italic>\u2009=\u20090.99; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200942%), and blood loss (MD\u2009=\u200917.72; 95%CI: -41.27 to 5.82; <jats:italic>P<\/jats:italic>\u2009=\u20090.10; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090%) in pediatric patients. However, HES significantly decreased the blood platelet count (MD\u2009=\u200920.99; 95%CI: -32.08 to -9.90; <jats:italic>P<\/jats:italic>\u2009=\u20090.0002; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200928%) and increased the length of ICU stay (MD\u2009=\u20090.94; 95%CI: 0.18 to 1.70; <jats:italic>P<\/jats:italic>\u2009=\u20090.02; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200946%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Volume expansion with 6% HES significantly decreased the platelet count and increased the length of ICU stay, also might have an adverse effect on renal function. Therefore HES is not recommended for pediatric patients, which safety needs more high quality RCTs and studies to confirm in future.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13054-015-0815-y","type":"journal-article","created":{"date-parts":[[2015,2,23]],"date-time":"2015-02-23T16:49:39Z","timestamp":1424710179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Safety evaluation on low-molecular-weight hydroxyethyl starch for volume expansion therapy in pediatric patients: a meta-analysis of randomized controlled trials"],"prefix":"10.1186","volume":"19","author":[{"given":"Lixia","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,1]]},"reference":[{"key":"815_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJMoa070716","volume":"358","author":"FM Brunkhorst","year":"2008","unstructured":"Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125\u201339.","journal-title":"N Engl J Med"},{"key":"815_CR2","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1056\/NEJMoa1209759","volume":"367","author":"JA Myburgh","year":"2012","unstructured":"Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, et al. Hydroxyethyl starch or saline for volume expansion in intensive care. N Engl J Med. 2012;367:1901\u201311.","journal-title":"N Engl J Med"},{"key":"815_CR3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1056\/NEJMoa1204242","volume":"367","author":"A Perner","year":"2012","unstructured":"Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Aneman A, et al. Hydroxyethyl starch 130\/0.42 versus Ringer\u2019s acetate in severe sepsis. N Engl J Med. 2012;367:124\u201334.","journal-title":"N Engl J Med"},{"key":"815_CR4","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s00134-012-2472-9","volume":"38","author":"K Reinhart","year":"2012","unstructured":"Reinhart K, Perner A, Sprung CL, Jaeschke R, Schortgen F, Johan Groeneveld AB, et al. Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med. 2012;38:368\u201383.","journal-title":"Intensive Care Med"},{"key":"815_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1152\/jappl.1995.78.1.179","volume":"78","author":"C Papastamelos","year":"1995","unstructured":"Papastamelos C, Panitch HB, England SE, Allen JL. Developmental changes in chest wall compliance in infancy and early childhood. J Appl Physiol. 1995;78:179\u201384.","journal-title":"J Appl Physiol"},{"key":"815_CR6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00431-002-1025-6","volume":"16","author":"H Senzaki","year":"2002","unstructured":"Senzaki H, Akagi M, Hishi T, Ishizawa A, Yanagisawa M, Masutani S, et al. Age-associated changes in arterial elastic properties in children. Eur J Pediatr. 2002;16:547\u201351.","journal-title":"Eur J Pediatr"},{"key":"815_CR7","doi-asserted-by":"publisher","first-page":"H500","DOI":"10.1152\/ajpcell.1998.274.2.C500","volume":"274","author":"D Chemla","year":"1998","unstructured":"Chemla D, H\u00e9bert JL, Coirault C, Zamani K, Suard I, Colin P, et al. Total arterial compliance estimated by stroke volume-to-aortic pulse pressure ratio in humans. Am J Physiol. 1998;274:H500\u20135.","journal-title":"Am J Physiol"},{"key":"815_CR8","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264\u20139.","journal-title":"Ann Intern Med"},{"key":"815_CR9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/0272989X12458724","volume":"33","author":"S Dias","year":"2013","unstructured":"Dias S, Sutton AJ, Ades AE, Welton NJ. Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med Decis Making. 2013;33:607\u201317.","journal-title":"Med Decis Making"},{"key":"815_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1\u201312.","journal-title":"Control Clin Trials"},{"key":"815_CR11","first-page":"343","volume":"18","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;18:343\u201352.","journal-title":"BMJ"},{"key":"815_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.","journal-title":"BMC Med Res Methodol"},{"key":"815_CR13","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539\u201358.","journal-title":"Stat Med"},{"key":"815_CR14","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1080\/08035250500529345","volume":"95","author":"JM Liet","year":"2006","unstructured":"Liet JM, Kuster A, Denizot S, Caillaux-Varin G, Gras-Leguen C, Roz\u00e9 JC. Effects of hydroxyethyl starch on cardiac output in hypotensive neonates: a comparison with isotonic saline and 5% albumin. Acta Pediatrica. 2006;95:555\u201360.","journal-title":"Acta Pediatrica"},{"key":"815_CR15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1017\/S0265021508003888","volume":"25","author":"T Standl","year":"2008","unstructured":"Standl T, Lochbuehler H, Galli C, Reich A, Dietrich G, Hagemann H. HES 130\/0.4 (Voluven) or human albumin in children younger than 2\u00a0yr undergoing non-cardiac surgery. A prospective, randomized, open label, multicentre trial. Eur J Anaesthesiol. 2008;25:437\u201345.","journal-title":"Eur J Anaesthesiol"},{"key":"815_CR16","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1097\/CCM.0b013e3181e81165","volume":"38","author":"SO Akech","year":"2010","unstructured":"Akech SO, Jemutai J, Timbwa M, Kivaya E, Boga M, Fegan G, et al. Phase II trial on the use of Dextran 70 or starch for supportive therapy in Kenyan children with severe malaria. Crit Care Med. 2010;38:1630\u20136.","journal-title":"Crit Care Med"},{"key":"815_CR17","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1097\/ALN.0b013e3182a6b387","volume":"119","author":"P Van der Linden","year":"2013","unstructured":"Van der Linden P, De Vill\u00e9 A, Hofer A, Heschl M, Gombotz H. Six percent hydroxyethyl starch 130\/0.4 (Voluven\u00ae) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in pediatric patients. Anesthesiology. 2013;119:1296\u2013309.","journal-title":"Anesthesiology"},{"key":"815_CR18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/01.PCC.0000074262.84240.1E","volume":"4","author":"JM Liet","year":"2003","unstructured":"Liet JM, Bellouin AS, Boscher C, Lejus C, Roz\u00e9 JC. Plasma volume expansion by medium molecular weight hydroxyethyl starch in neonates: a pilot study. Pediatr Crit Care Med. 2003;4:305\u20137.","journal-title":"Pediatr Crit Care Med"},{"key":"815_CR19","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1097\/CCM.0b013e3181958c81","volume":"37","author":"C Hanart","year":"2009","unstructured":"Hanart C, Khalife M, De Vill\u00e9 A, Otte F, De Hert S, Van der Linden P. Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130\/0.4. Crit Care Med. 2009;37:696\u2013701.","journal-title":"Crit Care Med"},{"key":"815_CR20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3109\/0886022X.2012.747139","volume":"35","author":"FG Akkucuk","year":"2013","unstructured":"Akkucuk FG, Kanbak M, Ayhan B, Celebioglu B, Aypar U. The effect of HES (130\/0.4) usage as the priming solution on renal function in children undergoing cardiac surgery. Ren Fail. 2013;35:210\u20135.","journal-title":"Ren Fail"},{"key":"815_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1399-6576.2005.00881.x","volume":"50","author":"K Chong Sung","year":"2006","unstructured":"Chong Sung K, Kum Suk P, Mi Ja Y, Kyoung OK. Effects of intravascular volume therapy using hydroxyethyl starch (130\/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial. Acta Anaesthesiol Scand. 2006;50:108\u201311.","journal-title":"Acta Anaesthesiol Scand"},{"key":"815_CR22","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/j.1365-2044.2007.05186.x","volume":"62","author":"T Haas","year":"2007","unstructured":"Haas T, Preinreich A, Oswald E, Pajk W, Berger J, Kuehbacher G, et al. Effects of albumin 5% and artificial colloids on clot formation in small infants. Anaesthesia. 2007;62:1000\u20137.","journal-title":"Anaesthesia"},{"key":"815_CR23","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa044057","volume":"353","author":"BA Wills","year":"2005","unstructured":"Wills BA, Nguyen MD, Ha TL, Dong TH, Tran TN, Le TT, et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med. 2005;353:877\u201389.","journal-title":"N Engl J Med"},{"key":"815_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1053\/j.jvca.2006.01.029","volume":"21","author":"TK Sahoo","year":"2007","unstructured":"Sahoo TK, Chauhan S, Sahu M, Bisoi A, Kiran U. Effects of hemodilution on outcome after modified Blalock-Taussig shunt operation in children with cyanotic congenital heart disease. J Cardiothorac Vasc Anesth. 2007;21:179\u201383.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"815_CR25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1399-6576.2008.01863.x","volume":"53","author":"WA Osthaus","year":"2009","unstructured":"Osthaus WA, Witt L, Johanning K, Boethig D, Winterhalter M, Huber D, et al. Equal effects of gelatin and hydroxyethyl starch (6% HES 130\/0.42) on modified thrombelastography in children. Acta Anaesthesiol Scand. 2009;53:305\u201310.","journal-title":"Acta Anaesthesiol Scand"},{"key":"815_CR26","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/j.1460-9592.2008.02756.x","volume":"18","author":"L Witt","year":"2008","unstructured":"Witt L, Osthaus WA, J\u00fcttner B, Heimbucher C, S\u00fcmpelmann R. Alteration of anion gap and strong ion difference caused by hydroxyethyl starch 6% (130\/0.42) and gelatin 4% in children. Paediatr Anaesth. 2008;18:934\u20139.","journal-title":"Paediatr Anaesth"},{"key":"815_CR27","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1086\/427505","volume":"40","author":"K Maitland","year":"2005","unstructured":"Maitland K, Pamba A, English M, Peshu N, Marsh K, Newton C, et al. Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit. Clin Infect Dis. 2005;40:538\u201345.","journal-title":"Clin Infect Dis"},{"key":"815_CR28","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1365-2141.2004.05312.x","volume":"128","author":"K Maitland","year":"2005","unstructured":"Maitland K, Pamba A, English M, Peshu N, Levin M, Marsh K, et al. Pre-transfusion management of children with severe malarial anaemia: a randomised controlled trial of intravascular volume expansion. Br J Haematol. 2005;128:393\u2013400.","journal-title":"Br J Haematol"},{"key":"815_CR29","first-page":"s97","volume":"91","author":"S Kalayanarooj","year":"2008","unstructured":"Kalayanarooj S. Choice of colloidal solutions in dengue hemorrhagic fever patients. J Med Assoc Thai. 2008;91:s97\u2013103.","journal-title":"J Med Assoc Thai"},{"key":"815_CR30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1136\/bmj.317.7153.235","volume":"317","author":"Cochrane Injuries Group Albumin Reviewers","year":"1998","unstructured":"Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ. 1998;317:235\u201340.","journal-title":"BMJ"},{"key":"815_CR31","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/01.CCM.0000194725.48928.3A","volume":"34","author":"JL Vincent","year":"2006","unstructured":"Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34:344\u201353.","journal-title":"Crit Care Med"},{"key":"815_CR32","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s00134-009-1521-5","volume":"35","author":"C Hartog","year":"2009","unstructured":"Hartog C, Reinhart K. CONTRA: hydroxyethyl starch solutions are unsafe in critically ill patients. Intensive Care Med. 2009;35:1337\u201342.","journal-title":"Intensive Care Med"},{"key":"815_CR33","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1213\/ANE.0b013e3181eaff91","volume":"112","author":"CS Hartog","year":"2011","unstructured":"Hartog CS, Bauer M, Reinhart K. The efficacy and safety of colloid resuscitation in the critically ill. Anesth Analg. 2011;112:156\u201364.","journal-title":"Anesth Analg"},{"key":"815_CR34","doi-asserted-by":"crossref","unstructured":"Haase N, Perner A, Hennings LI, Siegemund M, Lauridsen B, Wetterslev M, et al. Hydroxyethyl starch 130\/0.38-0.45 versus crystalloid or albumin inpatients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ. 2013;346:f839.","DOI":"10.1136\/bmj.f839"},{"key":"815_CR35","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1034\/j.1399-6576.2003.00220.x","volume":"47","author":"O Sander","year":"2003","unstructured":"Sander O, Reinhart K, Meier-Helmann A. Equivalence of hydroxyethyl starch HES 130\/0.4 and HES 200\/0.5 for perioperative volume replacement in major gynaecological surgery. Acta Anaesthesiol Scand. 2003;47:1151\u20138.","journal-title":"Acta Anaesthesiol Scand"},{"key":"815_CR36","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1097\/00000539-200006000-00011","volume":"90","author":"BE Miller","year":"2000","unstructured":"Miller BE, Guzzetta NA, Tosone SR, Levy JH. Rapid evaluation of coagulopathies after cardiopulmonary bypass in children using modified thromboelastography. Anesth Analg. 2000;90:1324\u201330.","journal-title":"Anesth Analg"},{"key":"815_CR37","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jtcvs.2011.03.015","volume":"142","author":"RM Sniecinski","year":"2011","unstructured":"Sniecinski RM, Levy JH. Bleeding and management of coagulopathy. J Thorac Cardiovasc Surg. 2011;142:662\u20137.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"815_CR38","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s00134-004-2388-0","volume":"30","author":"D Paparella","year":"2004","unstructured":"Paparella D, Brister SJ, Buchanan MR. Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med. 2004;30:1873\u201381.","journal-title":"Intensive Care Med"},{"key":"815_CR39","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0003-4975(01)02745-X","volume":"72","author":"MM Wilkes","year":"2001","unstructured":"Wilkes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg. 2001;72:527\u201333.","journal-title":"Ann Thorac Surg"},{"key":"815_CR40","first-page":"413","volume":"1383","author":"R Leberle","year":"2014","unstructured":"Leberle R, Ernstberger A, Loibl M, Merkl J, Bunz M, Creutzenberg M, et al. Association of high volumes of hydroxyethyl starch with acute kidney injury in elderly trauma patients. Injury. 2014;1383:413\u20136.","journal-title":"Injury"},{"key":"815_CR41","doi-asserted-by":"crossref","unstructured":"Hamaji A, Hajjar L, Caiero M, Almeida J, Nakamura RE, Osawa EA, et al. Volume replacement therapy during hip arthroplasty using hydroxyethyl starch (130\/0.4) compared to lactated Ringer decreases allogeneic blood transfusion and postoperative infection. Braz J Anesthesiol. 2013;63:27\u201335.","DOI":"10.1016\/j.bjane.2012.03.002"},{"key":"815_CR42","doi-asserted-by":"crossref","unstructured":"Serpa Neto A, Veelo DP, Peireira VG, de Assuncao MS, Manetta JA, Esposito DC, et al. Volume expansion with hydroxyethyl starches in patients with sepsis is associated with an increased incidence of acute kidney injury and use of renal replacement therapy: a systematic review and meta-analysis of the literature. J Crit Care. 2014;29:185.e1-7.","DOI":"10.1016\/j.jcrc.2013.09.031"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-015-0815-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-015-0815-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-015-0815-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-015-0815-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T09:39:31Z","timestamp":1627897171000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-015-0815-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["815"],"URL":"https:\/\/doi.org\/10.1186\/s13054-015-0815-y","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"6 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"79"}}